期刊
EMBO REPORTS
卷 19, 期 10, 页码 -出版社
WILEY
DOI: 10.15252/embr.201745517
关键词
acute-phase response; inflammation; innate immunity; lipopolysaccharide; serum amyloid A
资金
- National Institutes of Health [R56 AI040176]
- Fundo para o Desenvolvimento das Ciencias e da Tecnologia [026/2016/A1, 072/2015/A1]
- University of Macau [MYRG2016-00152-ICMS-QRCM, CPG2015-00018-ICMS]
Lipopolysaccharide (LPS) is a major microbial mediator for tissue injury and sepsis resulting from Gram-negative bacterial infection. LPS is an external factor that induces robust expression of serum amyloid A (SAA), a major constituent of the acute-phase proteins, but the relationship between SAA expression and LPS-induced tissue injury remains unclear. Here, we report that mice with inducible transgenic expression of human SAA1 are partially protected against inflammatory response and lung injury caused by LPS and cecal ligation and puncture (CLP). In comparison, transgenic SAA1 does not attenuate TNF-induced lung inflammation and injury. The SAA1 expression level correlates inversely with the endotoxin concentrations in serum and lung tissues since SAA1 binds directly to LPS to form a complex that promotes LPS uptake by macrophages. Disruption of the SAA1-LPS interaction with a SAA1-derived peptide partially reduces the protective effect and exacerbates inflammation. These findings demonstrate that acute-phase SAA provides innate feedback protection against LPS-induced inflammation and tissue injury.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据